CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases

Phase 1MER511
Related Companies

Read the original article

Published by PR Newswire Pharma on August 31, 2026 10:45 AM

Read Original